» Articles » PMID: 3612173

Neuronal Size and Density in the Nucleus Basalis of Meynert in Alzheimer's Disease

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 1987 Jun 1
PMID 3612173
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Neuronal size and density were measured in the nucleus basalis of Meynert in 7 elderly patients with Alzheimer's disease (AD) and 7 controls. The number of neurons in AD patients was reduced to 36% of the control value. The population of large neurons (perikaryonal diameter greater than 30 micron) had disappeared almost completely. In addition to cell death, shrinkage may play a role, since there were relatively more neurons in the small size classes in the AD patients than in the controls. The nuclear diameter was reduced to 79% of the control values, and the perikaryonal diameter to 75%, and thus the cytoplasm/nucleus ratio was close to equal in the two groups. Correlations of the morphometric measurements with choline acetyltransferase activities and muscarinic receptor binding are also presented.

Citing Articles

Compensatory cognition in neurological diseases and aging: A review of animal and human studies.

Kanishka , Jha S Aging Brain. 2023; 3:100061.

PMID: 36911258 PMC: 9997140. DOI: 10.1016/j.nbas.2022.100061.


Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.

Lin C, Frigerio I, Boon B, Zhou Z, Rozemuller A, Bouwman F Brain. 2022; 145(8):2869-2881.

PMID: 35259207 PMC: 9420016. DOI: 10.1093/brain/awac093.


Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.

Moss D, Perez R Curr Alzheimer Res. 2021; 18(13):1010-1022.

PMID: 34911424 PMC: 8855657. DOI: 10.2174/1567205018666211215150547.


The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain.

Gasiorowska A, Wydrych M, Drapich P, Zadrozny M, Steczkowska M, Niewiadomski W Front Aging Neurosci. 2021; 13:654931.

PMID: 34326765 PMC: 8315271. DOI: 10.3389/fnagi.2021.654931.


Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.

Geula C, Dunlop S, Ayala I, Kawles A, Flanagan M, Gefen T J Neurochem. 2021; 158(6):1394-1411.

PMID: 34272732 PMC: 8458251. DOI: 10.1111/jnc.15471.